Springworks Therapeutics logo

Springworks Therapeutics share price today

(SWTX)

Springworks Therapeutics share price is $35.59 & ₹3,024.30 as on 21 Dec 2024, 2.30 'hrs' IST

$35.59

0.81

(2.33%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Springworks Therapeutics share price in Dollar and Rupees. Guide to invest in Springworks Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Springworks Therapeutics. Get details on the Indian mutual funds that are investing in Springworks Therapeutics. Get Analyst recommendations and forecasts along with all the Springworks Therapeutics's financials.

Springworks Therapeutics share price movements

  • Today's Low: $34.60
    Today's High: $35.94

    Day's Volatility :3.73%

  • 52 Weeks Low: $28.21
    52 Weeks High: $53.92

    52 Weeks Volatility :47.68%

Springworks Therapeutics Returns

PeriodSpringworks Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
5.78%
-12.2%
0.0%
6 Months
-3.55%
-6.9%
0.0%
1 Year
-2.39%
2.7%
0.0%
3 Years
-51.01%
-0.2%
-17.3%

Springworks Therapeutics Key Statistics

in dollars & INR

Previous Close
$34.78
Open
$34.56
Today's High
$35.94
Today's Low
$34.6
Market Capitalization
$2.6B
Today's Volume
$1.3M
52 Week High
$53.92
52 Week Low
$28.21
Revenue TTM
$135.5M
EBITDA
$-292.3M
Earnings Per Share (EPS)
$-3.89
Profit Margin
-203.09%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-59.33%

How to invest in Springworks Therapeutics from India?

It is very easy for Indian residents to invest directly in Springworks Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Springworks Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Springworks Therapeutics or SWTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Springworks Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Springworks Therapeutics shares which would translate to 0.024 fractional shares of Springworks Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Springworks Therapeutics, in just a few clicks!

Returns in Springworks Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Springworks Therapeutics investment value today

Current value as on today

₹1,02,208

Returns

₹2,208

(+2.21%)

Returns from Springworks Therapeutics Stock

₹112 (false-0.11%)

Dollar Returns

₹2,095 (+2.1%)

Indian investors sentiment towards Springworks Therapeutics

-36%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Springworks Therapeutics on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -36% less investors are searching Springworks Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Springworks Therapeutics

  • FMR Inc

    14.98%

  • Vanguard Group Inc

    9.02%

  • BlackRock Inc

    7.55%

  • Deep Track Capital, LP

    5.17%

  • T. Rowe Price Associates, Inc.

    4.73%

  • Boxer Capital LLC

    4.60%

Analyst Recommendation on Springworks Therapeutics

Buy

    93%Buy

    6%Hold

    0%Sell

Based on 15 Wall street analysts offering stock ratings for Springworks Therapeutics(by analysts ranked 0 to 5 stars)

Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
14
12
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Springworks Therapeutics

What analysts predicted

Upside of 91.42%

Current:

$35.59

Target:

$68.13

Insights on Springworks Therapeutics

  • Price Movement

    In the last 7 days, SWTX stock has moved down by -9.2%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 59.73M → 49.30M (in $), with an average decrease of 17.5% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -39.91M → -53.53M (in $), with an average decrease of 34.1% per quarter
  • SWTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 33.4% return, outperforming this stock by 24.6%
  • SWTX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 20.5% return, outperforming this stock by 70.1%
  • Price to Sales

    ForSWTX every $1 of sales, investors are willing to pay $18.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.5 for every $1 of sales.

Springworks Therapeutics Technicals Summary

Sell

Neutral

Buy

Springworks Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Springworks Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Springworks Therapeutics Inc
-7.1%
-3.55%
-2.39%
-51.01%
-4.95%
Regeneron Pharmaceuticals, Inc.
-4.72%
-33.43%
-16.35%
14.7%
89.27%
Biontech Se
9.01%
28.55%
5.71%
-57.13%
220.59%
Alnylam Pharmaceuticals, Inc.
-3.99%
7.16%
25.05%
27.48%
103.59%
Vertex Pharmaceuticals Incorporated
-12.1%
-16.49%
-2.12%
78.05%
80.31%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Springworks Therapeutics Inc
NA
NA
NA
-3.14
-0.59
-0.34
NA
7.17
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.05
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Springworks Therapeutics Inc
Buy
$2.6B
-4.95%
NA
-203.09%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
89.27%
17.67
33.61%
Biontech Se
Buy
$26.8B
220.59%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.7B
103.59%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$115.2B
80.31%
32.84
-4.51%

Springworks Therapeutics Dividend announcements

  • Springworks Therapeutics Earnings

    Springworks Therapeutics’s price-to-earnings ratio stands at None

    Read More

About Springworks Therapeutics

springworks therapeutics is a mission-driven medicines company dedicated to developing innovative potential new treatments for unserved and underserved patient communities. originally conceived by pfizer, springworks presents a groundbreaking new model for collaboration rooted in connecting scientists, biopharmaceutical partners, patient groups, funders and philanthropists to advance and deliver transformative science to patients. through our partnerships, we remain focused on providing innovative treatments an additional avenue for development, with our launch pipeline focused on advancing potential programs for four diseases, all of which currently have no cure, including desmoid tumor, neurofibromatosis, hereditary xerocytosis and post-traumatic stress disorder. our name is a reflection of our approach to drug development: we’re springing into action to deliver treatments to people who are in great need and without alternatives.
Organization
Springworks Therapeutics
Employees
305
CEO
Mr. Saqib Islam J.D.
Industry
Health Technology

Management People of Springworks Therapeutics

NameTitle
Mr. Saqib Islam J.D.
CEO & Director
Mr. Francis I. Perier Jr., M.B.A.
Chief Financial Officer
Dr. Badreddin Edris Ph.D.
Chief Operating Officer
Dr. James Cassidy M.D., Ph.D.
Chief Medical Officer
Mr. Michael P. Nofi
Chief Accounting Officer
Mr. Tai-An Lin Ph.D.
Chief Scientific Officer
Ms. Kim Diamond
Vice President of Communications & Investor Relations
Mr. Herschel S. Weinstein J.D.
General Counsel & Secretary
Mr. Daniel J. Pichl
Chief People Officer
Mr. Bhavesh Ashar M.B.A.
Chief Commercial Officer

Important FAQs about investing in Springworks Therapeutics from India :

What is Springworks Therapeutics share price today?

Springworks Therapeutics share price today stands at $35.59, Open: $34.56 ; Previous Close: $34.78 ; High: $35.94 ; Low: $34.60 ; 52 Week High: $53.92 ; 52 Week Low: $28.21. The stock opens at $34.56, after a previous close of $34.78. The stock reached a daily high of $35.94 and a low of $34.60, with a 52-week high of $53.92 and a 52-week low of $28.21.

Can Indians buy Springworks Therapeutics shares?

Yes, Indians can invest in the Springworks Therapeutics (SWTX) from India.

With INDmoney, you can buy Springworks Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Springworks Therapeutics at zero transaction cost.

How can I buy Springworks Therapeutics shares from India?

It is very easy to buy Springworks Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Springworks Therapeutics be purchased?

Yes, you can buy fractional shares of Springworks Therapeutics with INDmoney app.

What are the documents required to start investing in Springworks Therapeutics stocks?

To start investing in Springworks Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Springworks Therapeutics

Today’s highest price of Springworks Therapeutics (SWTX) is $35.94.

Today’s lowest price of Springworks Therapeutics (SWTX) is $34.60.

What is today's market capitalisation of Springworks Therapeutics

Today's market capitalisation of Springworks Therapeutics SWTX is 2.6B

What is the 52 Week High and Low Range of Springworks Therapeutics

  • 52 Week High

    $53.92

  • 52 Week Low

    $28.21

What are the historical returns of Springworks Therapeutics?

  • 1 Month Returns

    -7.1%

  • 3 Months Returns

    -3.55%

  • 1 Year Returns

    -2.39%

  • 5 Years Returns

    -4.95%

Who is the Chief Executive Officer (CEO) of Springworks Therapeutics

Mr. Saqib Islam J.D. is the current Chief Executive Officer (CEO) of Springworks Therapeutics.